Credit: A medical worker administers a shot of the Nuvaxovid vaccine against Covid-19 by Novavax at the Tegel vaccination center on February 28, 2022 in Berlin, Germany. Germany is launching Novavax vaccinations this week, also in the hope that at least some of people who have so far refused to be vaccinated with mRNA vaccines will see Novavax as a desirable alternative. (Photo by Carsten Koall/Getty Images)

Novavax cuts losses and nears 100 million COVID-19 doses

Survey of Virginia students finds alarming rates of anxiety, suicidal thoughts

Montgomery Co. monitoring wastewater for COVID-19

Access to maternity care on the decline in greater DC area

Study: More than 37 million US motorists drive drowsy at least once a year

Paxlovid reduces risk of long Covid, Veterans Affairs study finds